Abstract

Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematological disorders presenting with an increased proliferation in one or several hematological cell lines. Renal manifestations of MPN have not been fully characterized so far. To morphologically assess the potential renal involvement in MPN patients, we analyzed histomorphological findings of a post-mortem cohort (n = 57) with a disease history of Philadelphia-negative MPN including polycythaemia vera, primary myelofibrosis, essential thrombocythemia, or chronic myelomonocytic leukemia (CMML). Seven (12.2%) patients presented with a pattern of diffuse glomerulosclerosis not attributable to diabetic or hypertensive nephropathy. Weak C4d staining suggestive for chronic thrombotic microangiopathy (TMA) was observed in 4/7 cases. Glomerulonephritis was excluded by light microscopy and immunohistochemistry. Patients with a pattern of diffuse glomerulosclerosis did not differ from the rest of the cohort regarding MPN subtype, disease duration, age, or sex. No significant proteinuria had been observed before death. Further findings attributed to MPNs were extramedullary hematopoiesis (n = 5; 8.8%) and tumor involvement in advanced disease (n = 4; 7.0%). Other common findings included arteriolosclerosis (n = 18; 31.6%) and signs of shock (n = 8; 14.0%). To our knowledge, this study is so far the largest investigating renal findings in MPN patients. There may be a causal relationship between idiopathic diffuse glomerular sclerosis and MPN, although its clinical significance and pathophysiology remain uncertain with TMA probably being relevant in a subgroup of cases. Our findings demonstrate the spectrum of renal findings in MPN from early to terminal disease of which hematologists should be aware of in daily clinical practice.

Highlights

  • Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders presenting with dysregulated proliferation of one or several lines of myeloid blood cells

  • We reviewed all autopsy reports performed at our institution between 2000 and 2020 in order to identify patients with a diagnosis of MPN (PV, essential thrombocythemia (ET), primary myelofibrosis (PMF), MPN-U) or MDS/ MPN, diagnosed either at lifetime or at the time of autopsy (n = 57)

  • This post-mortem study provides an overview of renal findings of MPN and MDS/MPN patients

Read more

Summary

Introduction

Myeloproliferative neoplasms (MPN) are clonal hematopoietic stem cell disorders presenting with dysregulated proliferation of one or several lines of myeloid blood cells. Entities include chronic myelogenous leukemia (CML), polycythaemia vera (PV), primary myelofibrosis (PMF), essential thrombocythemia (ET), and the very rare forms of chronic neutrophilic or eosinophilic leukemia [1]. Besides these classical subtypes of MPN, there are entities showing both features of myeloproliferative and myelodysplastic. Systematic histopathological examination of kidneys of MPN patients has not been reported for many years with the exception of anecdotal reports or small case series. In 2011, Said et al published a series of eleven indication biopsies of MPN patients [4]. The patients had been biopsied due to nephrotic range proteinuria (i.e., > 3 g/day) or chronic renal

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call